These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31070426)

  • 21. Neural and behavioral correlates of attentional bias to cannabis cues among adults with cannabis use disorders.
    Ruglass LM; Shevorykin A; Dambreville N; Melara RD
    Psychol Addict Behav; 2019 Feb; 33(1):69-80. PubMed ID: 30589308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cannabis use disorders among adults in the United States during a time of increasing use of cannabis.
    Compton WM; Han B; Jones CM; Blanco C
    Drug Alcohol Depend; 2019 Nov; 204():107468. PubMed ID: 31586809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. On-line personalized feedback intervention for negative affect and cannabis: A pilot randomized controlled trial.
    Buckner JD; Zvolensky MJ; Lewis EM
    Exp Clin Psychopharmacol; 2020 Apr; 28(2):143-149. PubMed ID: 31204824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adolescent cannabis use and its associations with decision-making and episodic memory: Preliminary results from a longitudinal study.
    Duperrouzel JC; Hawes SW; Lopez-Quintero C; Pacheco-Colón I; Coxe S; Hayes T; Gonzalez R
    Neuropsychology; 2019 Jul; 33(5):701-710. PubMed ID: 30869932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Harm to others reduces the sunk-cost effect.
    Hamzagic ZI; Derksen DG; Matsuba MK; Aßfalg A; Bernstein DM
    Mem Cognit; 2021 Apr; 49(3):544-556. PubMed ID: 33169344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sunk Cost Effect in Individuals with Autism Spectrum Disorder.
    Fujino J; Tei S; Itahashi T; Aoki Y; Ohta H; Kanai C; Kubota M; Hashimoto RI; Nakamura M; Kato N; Takahashi H
    J Autism Dev Disord; 2019 Jan; 49(1):1-10. PubMed ID: 30014249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What were they thinking? Reducing sunk-cost bias in a life-span sample.
    Strough J; Bruine de Bruin W; Parker AM; Karns T; Lemaster P; Pichayayothin N; Delaney R; Stoiko R
    Psychol Aging; 2016 Nov; 31(7):724-736. PubMed ID: 27831712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mindfulness and decision making: sunk costs or escalation of commitment?
    Schmitzer-Torbert N
    Cogn Process; 2020 Aug; 21(3):391-402. PubMed ID: 32440716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence and correlates of treatment utilization among adults with cannabis use disorder in the United States.
    Wu LT; Zhu H; Mannelli P; Swartz MS
    Drug Alcohol Depend; 2017 Aug; 177():153-162. PubMed ID: 28599214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trends in cannabis use disorders among racial/ethnic population groups in the United States.
    Wu LT; Zhu H; Swartz MS
    Drug Alcohol Depend; 2016 Aug; 165():181-90. PubMed ID: 27317045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An fMRI study on sunk cost effect.
    Zeng J; Zhang Q; Chen C; Yu R; Gong Q
    Brain Res; 2013 Jun; 1519():63-70. PubMed ID: 23665393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rationality in medical treatment decisions: is there a sunk-cost effect?
    Bornstein BH; Emler AC; Chapman GB
    Soc Sci Med; 1999 Jul; 49(2):215-22. PubMed ID: 10414830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trends in cannabis use disorder by cigarette smoking status in the United States, 2002-2016.
    Weinberger AH; Pacek LR; Wall MM; Zvolensky MJ; Copeland J; Galea S; Nahvi S; Moeller SJ; Hasin DS; Goodwin RD
    Drug Alcohol Depend; 2018 Oct; 191():45-51. PubMed ID: 30077055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functioning of cannabis abuse and dependence criteria across two different countries: the United States and The Netherlands.
    Delforterie M; Creemers H; Agrawal A; Lynskey M; Jak S; van der Ende J; Verhulst F; Huizink A
    Subst Use Misuse; 2015 Jan; 50(2):242-50. PubMed ID: 25363693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Motivational and control mechanisms underlying adolescent cannabis use disorders: A prospective study.
    Cousijn J; van Benthem P; van der Schee E; Spijkerman R
    Dev Cogn Neurosci; 2015 Dec; 16():36-45. PubMed ID: 25922296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of a computerized distress intolerance intervention on electrocortical reactivity to cannabis and threat cues: A randomized controlled trial.
    Macatee RJ; Preston TJ; Afshar K; Schmidt NB; Cougle JR
    Psychol Addict Behav; 2022 Nov; 36(7):920-929. PubMed ID: 35129994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An exploratory follow-up study of cannabis use and decision-making under various risk conditions within adolescence.
    Thompson EL; Adams AR; Pacheco-Colón I; Lopez-Quintero C; Limia JM; Pulido W; Granja K; Paula DC; Gonzalez I; Ross JM; Duperrouzel JC; Hawes SW; Gonzalez R
    Neuropsychology; 2023 Jul; 37(5):544-556. PubMed ID: 36939602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Understanding decisions about sunk costs from older and younger adults' perspectives.
    Strough J; Schlosnagle L; DiDonato L
    J Gerontol B Psychol Sci Soc Sci; 2011 Nov; 66(6):681-6. PubMed ID: 21765061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reward, Control & Decision-Making in Cannabis Use Disorder: Insights from Functional MRI.
    Fatima H; Howlett AC; Whitlow CT
    Br J Radiol; 2019 Sep; 92(1101):20190165. PubMed ID: 31364398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risky decision-making as an antecedent or consequence of adolescent cannabis use: findings from a 2-year longitudinal study.
    Pacheco-Colón I; Lopez-Quintero C; Coxe S; Limia JM; Pulido W; Granja K; Paula DC; Gonzalez I; Ross JM; Duperrouzel JC; Hawes SW; Gonzalez R
    Addiction; 2022 Feb; 117(2):392-410. PubMed ID: 34184776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.